Category: Multiple Sclerosis

Effects of Physical Therapy and Dalfampridine on Function and Quality of Life in Non-ambulatory Individuals With Multiple Sclerosis: A Randomized Controlled Trial

Lacey E. Bromley, PhD; Bianca Weinstock-Guttman, MD Int J MS Care (2023) https://doi.org/10.7224/1537-2073.2023-063 Abstract Background: Decreases in mobility, quality of…

Stuart Schlossman

Behavioral Interventions to Improve Sleep Outcomes in Individuals With Multiple Sclerosis: A Systematic Review

 David Turkowitch, BS; Sarah J. Donkers, PT, PhD; Silvana L. Costa, PhD; Prasanna Vaduvathiriyan, MLS; Joy Williams, PT, DPT; Catherine…

Stuart Schlossman

The Impact of Insurance Restrictions in Newly Diagnosed Individuals With Multiple Sclerosis

 Ryan Mizell, MD  /   Int J MS Care (2024) 26 (1): 17–21. https://doi.org/10.7224/1537-2073.2022-069 ABSTRACT BACKGROUND: The medical system in the…

Stuart Schlossman

Awareness and Utilization of Public Physiotherapy Health Care Services to Support People With Multiple Sclerosis: A Health Care Service Audit

 Saduni Jasin-Pathiranage, B Physiotherapy, Hons; Lisa B. Grech, PhD, M Psych; Charlotte Scroggie, B Physiotherapy, Hons, Grad Cert Clinical Rehab;…

Stuart Schlossman

Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses

 Jacquelyn Bainbridge, PharmD; Rebecca Barnhart, PharmD; Ryan Fuller, PharmD; Van T. Hellerslia, PharmD; Julie Kidd, PharmD; Steven Merrill, PharmD; Emily…

Stuart Schlossman

The Role of Clinical Pharmacists in Patient-Centric Comprehensive Multiple Sclerosis Care

  ABSTRACT BACKGROUND: Individuals with multiple sclerosis (MS) may experience a variety of visible and invisible symptoms and, as they…

Stuart Schlossman

MS activity not likely to be affected by dairy or gluten foods, study finds

 No major differences seen in diets of patients who did or didn’t attain NEDA-3 by Marisa Wexler, MS | January…

Stuart Schlossman

U.S. Neurologists Eagerly Await Promising Oral BTKis in MS Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement

 Efficacy and safety of pipeline multiple sclerosis assets viewed as increasingly important characteristics, according to Spherix Global Insights.  [Exton PA, December 13,…

Stuart Schlossman

video: Biomarkers and Biosimilars for MS — an MS Views NOW event

 https://bit.ly/3SOafcO  Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR  Visit the MS Views and News articles and videos…

Stuart Schlossman

Learning About MS – Wellness Therapy – Impacts on Quality of Life

 Provided by #MSViewsandNews Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…

Stuart Schlossman

Categories

Latest Blog Posts